Original Article| Volume 4, ISSUE 1, P59-68, January 2010

Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins

Published:December 04, 2009DOI:


      Metabolic syndrome is associated with increased cardiovascular disease (CVD) risk, a risk that is significantly increased when accompanied by elevated low-density lipoprotein cholesterol (LDL-C). Whereas lifestyle therapies are the initial intervention of choice for both of these risk factors, it has not been clearly determined that this approach is efficacious when they occur concomitantly.


      To evaluate effects of supplementing a lifestyle program with a medical food and nutraceutical in individuals with metabolic syndrome and elevated LDL-C.


      We conducted a subgroup analysis of a 12-week, randomized trial in adults with metabolic syndrome; data from those with LDL-C ≥ 160 mg/dL were analyzed. Control-arm subjects were instructed to consume a modified Mediterranean-style, low-glycemic-load diet (MED, n = 12). Treatment-arm subjects received a phytochemical-enhanced diet (PED, n = 12) consisting of the same low-glycemic-load diet plus a medical food containing soy protein and plant sterols and a nutraceutical containing hops rho iso-alpha acids and acacia proanthocyanidins. All subjects received identical aerobic exercise counseling.


      At 12 weeks, mean weight loss did not differ between arms. However, the PED arm exhibited greater improvement than the MED arm (P < .05) in total cholesterol, LDL-C, non−high-density lipoprotein cholesterol (non-HDL-C), cholesterol/HDL-C, triglyceride/HDL-C, apolipoprotein (apo) B, apo B/apo A-1, homocysteine, total LDL particle number, and large HDL particle number. All individuals in the PED arm but only one third in the MED arm achieved LDL-C levels < 160 mg/dL.


      Individuals at high CVD risk benefit from a soy/phytosterol containing medical food and phytochemical supplemented lifestyle program.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Grundy S.M.
        • Brewer Jr., H.B.
        • Cleeman J.I.
        • Smith Jr., S.C.
        • Lenfant C.
        Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
        Circulation. 2004; 109: 433-438
        • Reisin E.
        • Alpert M.A.
        Definition of the metabolic syndrome: current proposals and controversies.
        Am J Med Sci. 2005; 330: 269-272
        • Jeppesen J.
        • Hansen T.W.
        • Rasmussen S.
        • Ibsen H.
        • Torp-Pedersen C.
        Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study.
        Atherosclerosis. 2006; 189: 369-374
        • Campbell C.Y.
        • Nasir K.
        • Sarwar A.
        • et al.
        Combined effect of high low-density lipoprotein cholesterol and metabolic syndrome on subclinical coronary atherosclerosis in white men without clinical evidence of myocardial ischemia.
        Am J Cardiol. 2007; 100: 840-843
        • Montalcini T.
        • Gorgone G.
        • Federico D.
        • et al.
        Association of LDL cholesterol with carotid atherosclerosis in menopausal women affected by the metabolic syndrome.
        Nutr Metab Cardiovasc Dis. 2005; 15: 368-372
        • Kawamoto R.
        • Tomita H.
        • Oka Y.
        • Kodama A.
        • Kamitani A.
        Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis.
        Intern Med. 2005; 44: 1232-1238
        • Giugliano D.
        • Esposito K.
        Mediterranean diet and metabolic diseases.
        Curr Opin Lipidol. 2008; 19: 63-68
        • Maki K.C.
        • Rains T.M.
        • Kaden V.N.
        • Raneri K.R.
        • Davidson M.H.
        Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults.
        Am J Clin Nutr. 2007; 85: 724-734
        • Sloth B.
        • Krog-Mikkelsen I.
        • Flint A.
        • et al.
        No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet.
        Am J Clin Nutr. 2004; 80: 337-347
        • Lukaczer D.
        • Liska D.J.
        • Lerman R.H.
        • et al.
        Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women.
        Nutrition. 2006; 22: 104-113
        • Lerman R.H.
        • Minich D.M.
        • Darland G.
        • et al.
        Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial.
        Nutr Metab (Lond). 2008; 5: 29
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        • Turner R.C.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Jeyarajah E.J.
        • Cromwell W.C.
        • Otvos J.D.
        Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.
        Clin Lab Med. 2006; 26: 847-870
        • Shrestha S.
        • Freake H.C.
        • McGrane M.M.
        • Volek J.S.
        • Fernandez M.L.
        A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake.
        J Nutr. 2007; 137: 1165-1170
        • Plat J.
        • Mensink R.P.
        Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women.
        FASEB J. 2002; 16: 258-260
        • Ruiu G.
        • Pinach S.
        • Veglia F.
        • et al.
        Phytosterol-enriched yogurt increases LDL affinity and reduces CD36 expression in polygenic hypercholesterolemia.
        Lipids. 2009; 44: 153-160
        • Harland J.I.
        • Haffner T.A.
        Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol.
        Atherosclerosis. 2008; 200: 13-27
        • Yusuf S.
        • Hawken S.
        • Ounpuu S.
        • et al.
        Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
        Lancet. 2004; 364: 937-952
        • Cromwell W.C.
        • Otvos J.D.
        • Keyes M.J.
        • et al.
        LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - Implications for LDL management.
        J Clin Lipidol. 2007; 1: 583-592
        • El Harchaoui K.
        • van der Steeg W.A.
        • Stroes E.S.
        • et al.
        Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
        J Am Coll Cardiol. 2007; 49: 547-553
        • Rosenson R.S.
        Low high-density lipoprotein cholesterol disorders and cardiovascular risk: contribution of associated low-density lipoprotein subclass abnormalities.
        Curr Opin Cardiol. 2005; 20: 313-317